• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Development of new therapeutic modality for acute renal failure by the inhibition of apoptosis

Research Project

Project/Area Number 13671582
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Anesthesiology/Resuscitation studies
Research InstitutionOkayama University

Principal Investigator

TAKAHASHI Toru  Okayama University, Graduate School of Medicine and Dentistry, Research Instructor, 大学院・医歯学総合研究科, 助手 (40252952)

Co-Investigator(Kenkyū-buntansha) SATOSHI Mizobuchi  Okayama University, Hospitals, Assistant Professor, 医学部・歯学部附属病院, 講師 (70311800)
Project Period (FY) 2001 – 2003
KeywordsIschemic acute renal failure / Heat shock protein / heme / heme oxygenase-1 / tin chloride(SnCl_2) / apoptosis
Research Abstract

Renal ischemia followed by reperfusion is known to result in renal epithelial cell injury, called ischemic acute renal failure (IARF), the major form of ARF of all episodes in intensive care units. IARF injury is thought to be due to reactive oxygen species (ROS) generated by reperfusion, which has been shown in part due to a rapid release of heme from microsomal cytochrome P450. The reversibility of renal function in IARF depends on the length. of the ischemic pretreatment prior to reperfusion, e.g., longer than 60 min ischemia resulting in an irreversible renal damage. We found that both heme oxygenase-1 (HO-1) mRNA and its enzyme activity were significantly increased in the reversible IARF model with a unilateral nephrectomy and the ligation of contralateral renal artery for 40 min. Inhibition of HO activity by tin mesoporphyrin (Sn-MP), a specific competitive inhibitor of HO, resulted both in a marked increase in intracellular heme content, and in the aggravation of renal function. … More Thus, HO-1 induction, plays an important role in the protection of renal dysfunction due to oxidative damage in IARF. However, only few studies have examined the effect of induction of HO-1 specifically in the target tissue in vivo without affecting other tissues. Tin chloride (SnCl_2) was reported to be a kidney-specific inducer of HO activity. We examined the effect of SnCl_2 administration on renal HO-1 induction, and on the renal injury in rats with IARF. SnCl_2 treatment specifically induced HO-1 mRNA, and protein in the proximal tubular epithelial cells of the kidney without apparent cell injury in the rat. SnCl_2 treatment before renal ischemia augmented the induct ion of HO-1 in IARF rats both at transcriptional and protein levels in renal epithelial cells. SnCl_2 pretreatment, which resulted in a transient decrease in microsomal heme concentration, ameliorated the ischemic renal injury as judged by significant decreases in serum creatinine and blood urea nitrogen levels and lesser tubular epithelial cell injuries. In contrast, inhibition of HO activity by treatment with Sn-MP, which resulted in an increase in microsomal heme concentration, abolished the beneficial effect of SnCl_2 pretreatment. These findings indicate that SnCl_2 pretreatment significantly improves the renal injury in rats with IARF by virtue of its specific HO-1 induction in renal epithelial cells. These findings also indicate that HO-1 induction plays an important role in conferring prot ection on renal cells from oxidative damages caused by heme, and that kidney-specific HO-1 expression is useful in the treatment of such conditions. Thus, SnCl_2, which has been simply thought to be toxic, may offer a new mode of treatment of IARF, because of its highly kidney-specific HO-1 inducing property. Less

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Narushi Toda, et al., 9 persons: "Tin chloride pretreatment prevents the renal injury in rats with ischemic acute renal failure"Critical Care Medicine. 30. 1512-1522 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Reiko Akagi, Toru Takahashi, Shigeru Sassa: "Fundamental role of heme oxygenase in the protection against ischemic acute renal failure"Japanese Journal of Pharmacology. 88. 127-132 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 高橋 徹, 森田 潔: "麻酔科医と基礎・臨床研究 敗血症性ショック 新たなる展開"南江堂. 233 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Toru Takahashi, Reiko Akagi, et al., 3 persons: "Heme Oxygenase in Biology and Medicine"Kluwer academic/Plenum publishers. 515 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Narushi Toda, Toru Takahashi, Satoshi Mizobuchi, Hiromi Fujii, Kiichi Nakahira, Shuji Takahashi, Masami Yamashita, Kiyoshi Morita, Masahisa Hirakawa, Reiko Akagi: "Tin chloride pretreatment prevents renal injury in rats with ischemic acute renal, failure"Critical Care Medicine. 30. 1512-1522 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Reiko Akagi, Toru Takahashi, Shigeu Sassa: "Fundamental role of heme oxygenase in the protection against ischemic acute renal failure"Japanese Journal of Pharmacology. 88. 127-132 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Toru Takahashi, Reiko Akagi, Hiroko Shimizu H, Masahisa Hirakawa, Shigeru Sassa: "Heme oxygenase-1 : A major player in the defense against the oxidative tissue injury"Heme Oxygenase in Biology and Medicine (Abraham NG, Alam J, Nath KA (Eds)) (Kluwer academic/Plenum publishers, New York). 387-397 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Toru Takahashi, Kiyoshi Morita: "The Kidney (In Japanese)"Septic shock : The new development (Namki, A & Imaizumi H (Eds)) (Nanko-do, Tokyo). 92-107 (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi